Increased Thrombotic Risk in COVID-19: Evidence and Controversy.

Publication date: Jul 01, 2023

The pandemic of respiratory disease caused by the novel coronavirus named SARS-CoV-2, which emerged at the end of 2019, is still ongoing [. ..].

Open Access PDF

Concepts Keywords
Coronavirus Caused
Covid Controversy
Increased Coronavirus
Pandemic Cov


Type Source Name
disease MESH COVID-19
disease MESH Emergency
drug DRUGBANK Coenzyme M
disease MESH infection
disease MESH inflammation
disease MESH cytokine storm
disease MESH immobilization
disease MESH morbidity
disease MESH complications
disease MESH pulmonary embolism
disease MESH deep vein thrombosis
disease MESH venous thromboembolism
disease MESH critically ill
disease MESH stroke
disease MESH ischemia
disease MESH acute coronary syndrome
disease MESH Thrombosis
disease IDO blood
drug DRUGBANK Angiotensin II
disease IDO production
drug DRUGBANK Epoprostenol
pathway KEGG Platelet activation
disease MESH death
disease MESH thromboembolism
disease MESH thrombotic microangiopathy
disease MESH thrombocytopenia
disease VO vaccine
disease MESH syndrome
disease VO Comirnaty
disease MESH bleeding
drug DRUGBANK Heparin
disease IDO history
disease MESH sepsis
disease IDO infectivity
disease IDO host
drug DRUGBANK Trestolone
drug DRUGBANK Enoxaparin
disease VO dose
drug DRUGBANK Oxygen
drug DRUGBANK Fondaparinux
disease VO effectiveness
disease VO frequency
disease MESH drug interactions
disease MESH malignancy
drug DRUGBANK Rivaroxaban
drug DRUGBANK Beroctocog alfa
drug DRUGBANK Immune Globulin Human
drug DRUGBANK Rituximab
drug DRUGBANK Eculizumab
drug DRUGBANK Thrombin
drug DRUGBANK Argatroban
drug DRUGBANK Bivalirudin
drug DRUGBANK Isoxaflutole
disease MESH pneumonia
disease VO organization
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Carboxyamidotriazole
disease IDO immunosuppression
disease MESH fatal outcome
disease MESH disseminated intravascular coagulation
disease VO vaccination
drug DRUGBANK Guanosine
disease VO report
disease MESH Respiratory Diseases
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Immune Thrombocytopenia

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *